Clinical News: Page 51

IMV: MRI exam mix shifts from outpatient to hospital settings
By Davin Korstjens
In 2024, the percentage of MRI procedures performed in an outpatient setting decreased by five percentage points to 66% of total MR procedures.
February 3, 2025
Mri Machine Screens
AI assistance improves CHD detection on prenatal ultrasound
By Amerigo Allegretto
AI boosts detection of major congenital heart defects (CHDs) on prenatal ultrasound, suggest findings presented at the Annual Pregnancy Meeting of the SMFM.
January 31, 2025
Smfm Ultrasound Ai Fetal Thumbnail
LLM performance varies based on language input
By Will Morton
Baidu’s AI chatbot Ernie Bot outperformed OpenAI’s ChatGPT-4.0 on interventional radiology questions in Chinese.
January 31, 2025
Chatgpthead
PET/CT guides surgery for primary aldosteronism
By Will Morton
PET/CT imaging with gallium-68 pentixafor can effectively guide surgery for patients with primary aldosteronism, a common cause of hypertension.
January 30, 2025
Apa 679bd41fd4afc Thumbnail
Ferumoxytol-enhanced MRA is safe for chronic kidney disease patients
By Kate Madden Yee
Ferumoxytol-enhanced MR angiography (MRA) appears to be safe for chronic kidney disease patients, researchers have reported.
January 29, 2025
Contrast Injector
Ultrafast MRI exam bests standard MRI for classifying breast cancers
By Amerigo Allegretto
An ultrafast MRI-based radiomics exam performs just as well as standard MRI and isn’t dependent on radiologist experience.
January 28, 2025
Ultrafast and standard MRI in a 30-year-old woman with triple-negative invasive ductal carcinoma. (A) Ultrafast MRI taken 16.8 seconds after contrast agent injection. (B) Standard MRI taken 58.8 seconds after contrast agent injection. Both images show an oval-shaped, irregular marginated, rim-enhancing mass in the left outer breast. For 3D tumor segmentation, the entire enhanced tumor margins were drawn from top to bottom of each tumor in axial views of U2 phase postcontrast ultrafast MRI and the initial phase postcontrast standard MRI. Among the 14 ultrafast images, U1 is the first phase in which the signal intensity of the hotspot region of interest of the tumor is 10% higher than the average signal intensity of unenhanced images. U2 is the immediate next phase of U1 and the well-established tumor enhancement time.
63% of heavy cannabis users show reduced working memory ability
By Kate Madden Yee
Functional MRI reveals that 63% of heavy lifetime cannabis users show reduced brain activity during a working memory task -- and that 68% of recent users also show this impact.
January 28, 2025
Cannabis Marijuana
GPT-4 could prove useful proofreading CT reports
By Will Morton
GPT-4 showed strong performance identifying factual errors in radiology reports, yet struggled to prioritize clinically significant findings.
January 28, 2025
Gpt
Does obesity improve NSCLC patients' postsurgery survival?
By Kate Madden Yee
Obesity appears to improve the overall post-surgery survival of patients with non-small cell lung cancer (NSCLC) by 21% compared with their nonobese peers.
January 28, 2025
2025 01 28 Radiology Lee Figure2 Thumbnail
New guidance issued on FAP-PET imaging
By Will Morton
Top U.S. and European nuclear medicine organizations have issued joint guidelines on the use of fibroblast activation protein (FAP)-PET imaging in cancer patients.
January 27, 2025
Cancer Target
IMV: Independent imaging centers face competition for CT scan volume
By Davin Korstjens
Independent imaging centers are experiencing increased competition for CT patients, according to the newly published IMV 2024 CT Market Outlook Report.
January 27, 2025
Ct Scanner Control Room2 Radiologist
Brain MRI tracks risk of stage IV breast cancer metastases
By Kate Madden Yee
Brain MRI shows promise for surveilling women at risk for asymptomatic stage IV breast cancer metastases by tracking molecular subtypes of the disease.
January 24, 2025
Brain Mri
Previous Page
Page 51 of 3670
Next Page